Natasha C Bergmann
Overview
Explore the profile of Natasha C Bergmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krogh L, Henriksen K, Stensen S, Skov-Jeppesen K, Bergmann N, Storling J, et al.
Eur J Endocrinol
. 2023 Jan;
188(1).
PMID: 36651162
Objective: The gut hormone glucose-dependent insulinotropic polypeptide (GIP) is an important regulator of glucose and bone metabolism. In rodents, the naturally occurring GIP variant, GIP(1-30)NH2, has shown similar effects as...
2.
Heimburger S, Hoe B, Nielsen C, Bergmann N, Hartmann B, Holst J, et al.
Diabetologia
. 2021 Aug;
64(11):2425-2431.
PMID: 34405256
Aims/hypothesis: Type 1 diabetes is characterised by reduced glucagon response to hypoglycaemia, increasing the risk of insulin treatment-associated hypoglycaemia known to hamper glycaemic control. We previously reported a glucagonotropic effect...
3.
Veedfald S, Bergmann N, Vilsboll T, Christensen M, Holst J, Knop F
Diabet Med
. 2021 May;
38(8):e14592.
PMID: 33955602
No abstract available.
4.
Hagemann C, Zhang C, Hansen H, Jorsal T, Rigbolt K, Madsen M, et al.
J Clin Endocrinol Metab
. 2020 Nov;
106(2):e966-e981.
PMID: 33135737
Context: The mechanisms underlying Roux-en-Y gastric bypass (RYGB) surgery-induced weight loss and the immediate postoperative beneficial metabolic effects associated with the operation remain uncertain. Enteroendocrine cell (EEC) secretory function has...
5.
Helsted M, Gasbjerg L, Lanng A, Bergmann N, Stensen S, Hartmann B, et al.
Bone
. 2020 Jul;
140:115553.
PMID: 32730920
The incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are well known for their insulinotropic effects and they are thought to affect bone homeostasis as mediators in...
6.
Lanng A, Gasbjerg L, Bergmann N, Gillum M, Rehfeld J, Helsted M, et al.
Alcohol
. 2020 Apr;
87:29-37.
PMID: 32335270
Ethanol intake increases plasma concentrations of triglycerides and chronic ethanol use impairs lipid metabolism and causes chronic inflammation. The gut plays an important role in metabolic handling of nutrients, including...
7.
Gasbjerg L, Helsted M, Hartmann B, Sparre-Ulrich A, Veedfald S, Stensen S, et al.
J Clin Endocrinol Metab
. 2020 Feb;
105(3).
PMID: 32077470
Context: The actions of both endogenous incretin hormones during a meal have not previously been characterized. Objective: Using specific receptor antagonists, we investigated the individual and combined contributions of endogenous...
8.
Bergmann N, Gasbjerg L, Heimburger S, Krogh L, Dela F, Hartmann B, et al.
Diabetes Care
. 2020 Jan;
43(3):588-596.
PMID: 31949084
Objective: Dual incretin receptor agonists in clinical development have shown reductions in body weight and hemoglobin A (HbA) in patients with type 2 diabetes, but the impact of glucose-dependent insulinotropic...
9.
Gasbjerg L, Bergmann N, Stensen S, Christensen M, Rosenkilde M, Holst J, et al.
Peptides
. 2019 Nov;
125:170183.
PMID: 31693916
Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) potentiate glucose-induced insulin secretion and are therefore thought to be responsible for the incretin effect. The magnitude of the incretin effect, defined...
10.
Heimburger S, Bergmann N, Augustin R, Gasbjerg L, Christensen M, Knop F
Peptides
. 2019 Nov;
125:170174.
PMID: 31689454
Accumulating evidence suggests that glucose-dependent insulinotropic polypeptide (GIP) in addition to its involvement in type 2 diabetic pathophysiology may be involved in the development of obesity and the pathogenesis of...